The type of therapy a cancer patient receives, largely depends on the trained eye of a pathologist.
Investigating diseased organs and tissues under the microscope is one of their tasks. However, human judgment is, by its very nature, subject to a certain degree of variation. To enhance the quality of diagnosis, scientists at Vetmeduni Vienna, the Medical University of Vienna and the Ludwig Boltzmann Institute for Cancer Research have developed a software that specifically identifies cell structures and proteins in order to provide reliable diagnoses. The scientists published their data in the journal Plos One.
Together with the company Tissuegnostics, the pathologist Lukas Kenner and his colleagues have developed a software that is able to identify cancer cells in tissue sections and demonstrate the presence of specific biomarkers on cells. The overall information provides a precise picture of the disease and leads to the most suitable treatment.
According to the results of the study, “Two independent pathologists concur with each other only in regard of every third diagnosis.”
“The recently developed software offers, for the first time, the option of eliminating the so-called inter-observer-variability, which is the systematic variability of judgement among different observers,” chief investigators Lukas Kenner and Helmut Dolznig explain.
Software identifies the severity of cancer
The Latest on: Diagnosis of cancer cells
via Google News
The Latest on: Diagnosis of cancer cells
- Debiopharm Grants a Worldwide Exclusive License to Merck KGaA, Darmstadt, Germany for the Development and Commercialization of Xevinapanton March 1, 2021 at 1:18 am
Under the terms of the license agreement, Merck KGaA, Darmstadt, Germany receives exclusive rights to develop and commercialize xevinapant worldwide, including in the U.S. Merck KGaA, Darmstadt, ...
- Cancer patients often can’t get full care with covid-19 bogging down medical facilitieson February 28, 2021 at 10:00 am
New vaccines promise relief. But any further surges in America’s hospitals and clinics will hamstring their ability to care for the sickest in oncology departments.
- My prostate cancer journey: Testosterone reduction, mini-radiation treatments, embedded radioactive seeds and lots of difficult side effectson February 26, 2021 at 3:49 pm
The year-long treatment’s effects made many things harder. And those seeds mean I might set off radiation detectors at borders and I can’t let my grandkids sit on my lap.
- CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129on February 26, 2021 at 5:57 am
This study aimed to screen the expression profiles of circRNA, miRNA, and mRNA of ovarian cancer cells induced by Torin 1 (10 µM). The expression profiles of circRNA, miRNA, and mRNA were analyzed ...
- A missing protein explains the appearance of tumor cells in people with Mulibrey syndromeon February 26, 2021 at 4:11 am
Researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), in collaboration with the Swiss Institute for Experimental Cancer Research (ISREC) have studied the ...
- Lung cancer symptoms: The simple finger test to find out if you’re at risk of the diseaseon February 25, 2021 at 12:02 am
LUNG cancer isn't reserved for older smokers, anyone can develop the deadly condition - and it's the most common cause of cancer death for both genders. Thankfully, an early diagnosis can make a big ...
- Shannen Doherty Health Update After Stage 4 Breast Cancer Diagnosison February 24, 2021 at 5:42 am
How is former 'Beverly Hills 90210' star and 'Dancing With the Stars' competitor Shannen Doherty doing after her stage 4 breast cancer diagnosis?
- Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cellson February 24, 2021 at 3:28 am
Cellular heterogeneity and the lack of metastatic biomarkers limit the diagnosis of and development of therapies for metastatic triple-negative breast cancer (TNBC). Thus, development of new ...
- Physics of tumours: Cancer cells become fluidised and squeeze through tissueon February 18, 2021 at 9:00 am
Working with colleagues from Germany and the US, researchers at Leipzig University have achieved a breakthrough in research into how cancer cells spread. In experiments, the team of biophysicists led ...
- Study: Immune cell makes prostate cancer therapy work better for Black menon February 18, 2021 at 12:05 am
Higher levels of a certain type of immune cell may explain why immunotherapy for prostate cancer is more effective in Black men than in white men, researchers say.
via Bing News